Mark Greener
This person does not yet have a bio.Articles by Mark Greener

From Worm to Fly, Y2H Takes Off
Mark Greener | | 6 min read
The yeast two-hybrid (Y2H) system can pump out vast quantities of data on a genome of any size.

Cancer Epigenetics Enters the Mainstream
Mark Greener | | 5 min read
has guided cancer research for decades.

Hot on Tolerance's Trail
Mark Greener | | 6 min read
Type 1 diabetes, rheumatoid arthritis, and Crohn disease seem clinically diverse, but they arise from acommon problem: poor discrimination between self and nonself.

TCAS: The Complex Analgesics
Mark Greener | | 2 min read
In the 1960s, researchers found that tricyclic antidepressants (TCAs) alleviated neuropathic pain, such as postherpetic neuralgia.

MAbs Turn 30
Mark Greener | | 7 min read
hler, two researchers at the Medical Research Council's (MRC) Laboratory of Molecular Biology in Cambridge, were investigating the mechanisms underlying the remarkable diversity of antibodies.

Did Enzymes Evolve to Capitalize on Quantum Tunneling?
Mark Greener | | 6 min read
In the early years of the 20th century, a new theory, quantum mechanics, revolutionized physicists' understanding of nature.

Now You're Signaling, With Gas
Mark Greener | | 8 min read
NO SIGNALING:© 2003 Annual ReviewsAll images redrawn from D. Boehning, S.H. Snyder, Ann Rev Neurosci, 26:105–31, 2003.Neuronal nitric oxide synthase (nNOS) is localized to NMDA receptors by the PDZ-domain adaptor protein PSD95. Calcium entry activates nNOS by a calcium/calmodulin-dependent mechanism. NO can diffuse to neighboring cells to activate soluble guanylyl cyclase or to nitrosylate cysteine residues on target proteins. Nitrosylation inhibits NMDA receptors providing a negative

Driving Changes in Ligand Theory
Mark Greener | | 3 min read
AGONIZING DIFFERENCES:© 2004 Macmillan Magazines Ltd.(A) GPCR agonists increase the proportion of active receptor states; inverse agonists decrease the proportion of active receptor states; and antagonists inhibit the action of other ligands. (B) In systems with low constitutive receptor activity, inverse agonists will seem to have minimal effect, but might have more effect in a system with high activity. (from Nat Rev Drug Disc, 3:577–626, 2004.)Pharmacologists traditionally divide l

Exploring Inositide Diversity
Mark Greener | | 6 min read
RELEASING THE SECOND MESSENGERS:© 2002 Garland Science/Taylor & Francis BooksIn this common pathway, activated phospholipase C-β hydrolyzes the inositide PI 4,5-bisphosphate to release diacylglyerol and inositol 1,4,5 trisphosphate. IP3 opens specific Ca2+ channels releasing the ions from the lumen of the endoplasmic reticulum. Diacylglycerol can be further cleaved to release arachidonic acid, a signaling molecule needed for the synthesis of other messengers such as prosta-glandins

A Deadly Selection
Mark Greener | | 6 min read
CALCULATED ESCAPE:Adapted from Y. Iwasa, et al., Proc R soc Lond B Sci, 270: 2573–8, 2003.In this example, genes can mutate at the rate u per gene, per cell division. Gross chromosomal changes occur at the rate p. For this tumor suppressor gene, TSP, Cancer cells have two functioning alleles prior to chemotherapy. Cell reproductive rates Ro-R4 are assumed equal, and a = R/(1-R). Therefore, the critical population size before escape from the therapeutic could happen, N*, can be represented

Enzymology's New Frontiers
Mark Greener | | 10+ min read
Investigators are learning about structures and rethinking old theories

One Man's JNK is a Scientist's Treasure
Mark Greener | | 7 min read
© 2003 Nature Publishing Group CROSS TALKING PATHWAYS: Schematic depicting the TNF-R1-induced pathways modulating apoptosis. Blocking the NF-kB-dependent pathway leads to sustained JNK activation and apoptosis. Conversely, blocking the TNF-a induced JNK pathway promotes cell survival. JNK may induce death by triggering mitochondrial events, either directly or indirectly, but its targets remain unknown. (From G. Franzoso et al., Cell Death Differ, 10:13-15. doi: 10.1038/sj.cdd4401154)

Steroid Action Gets a Rewrite
Mark Greener | | 7 min read
A TENTATIVE INTERPRETATION:Genomic actions of steroid hormones...Click for larger version (42K) Molecular biologists are rewriting the textbook explanation of steroid action. For 40 years, evidence has accumulated that some of the hormonally induced effects seemed too rapid for the classic model, in which steroids activate cytosolic receptors to modulate transcription. This evidence casts doubt on the so-called genomic pathway as the sole mode of steroid action. Increasing research now highl
Page 1 of 2 - 17 Total Items